Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. logo
LXRX

Lexicon Pharmaceuticals, Inc. (LXRX)

$2.123.41%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$2.02
Day's Range
$2.135
$1.31
52-Week Range
$4.87
1 month return4.65%
3 month return24.07%
1 year return55.24%
5 year return79.94%

Company Information

Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients' lives. Through its Genome5000™ program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon advanced one of these medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in neuropathic pain, heart failure, diabetes and metabolism and other indications.
OrganizationLexicon Pharmaceuticals, Inc.
Employees87
CEOMr. Lonnel Coats
IndustryHealth Technology

Analyst Recommendation

based on 4 analysts ratings

Hold
25%
Buy
75%
Hold
0%
Sell

Based on 4 Wall street analysts offering stock ratings for Lexicon Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 277.36%

Current

$2.12

Target

$8.0

Recommendation Trend

Based on 4 analyst

Current1M Ago3M Ago
Buy
1
7
6
Hold
3
2
3
Sell
0
0
0
Consensus
HOLD
BUY
BUY

Highlights

Market Capitalization
381.2M
Book Value
$0.76
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.61
PEG Ratio
-0.14
Wall Street Target Price
8.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
2.79
Enterprise Value
296.4M
Enterprise Value/Revenue
2371.29
Enterprise Value/Ebitda
-3.13

Technicals

Beta
1.36
50 Day MA
2.24
200 Day MA
2.32

Institutional Holdings

Artal Group S A

47.57%

Bvf Inc

7.5%

FMR Inc

2.8%

Vanguard Group Inc

2.79%

D. E. Shaw & Co LP

1.61%

NEA Management Company, LLC

1.26%

Discover more

Frequently Asked Questions

What is Lexicon Pharmaceuticals, Inc. share price today?

Can Indians buy Lexicon Pharmaceuticals, Inc. shares?

How can I buy Lexicon Pharmaceuticals, Inc. shares from India?

Can Fractional shares of Lexicon Pharmaceuticals, Inc. be purchased?

What are the documents required to start investing in Lexicon Pharmaceuticals, Inc. stocks?

What are today’s High and Low prices of Lexicon Pharmaceuticals, Inc.?

What are today’s traded volumes of Lexicon Pharmaceuticals, Inc.?

What is today’s market capitalisation of Lexicon Pharmaceuticals, Inc.?

What is the 52 Week High and Low Range of Lexicon Pharmaceuticals, Inc.?

How much percentage Lexicon Pharmaceuticals, Inc. is down from its 52 Week High?

How much percentage Lexicon Pharmaceuticals, Inc. is up from its 52 Week low?

What are the historical returns of Lexicon Pharmaceuticals, Inc.?

Who is the Chief Executive Officer (CEO) of Lexicon Pharmaceuticals, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*